Adjunctive Hyaluronic Acid Gel in Non-Surgical Periodontal Treatment of Patients With Diabetes Mellitus
The Effect of Hyaluronic Acid on Non-Surgical Periodontal Treatment in Patients With Diabetes Mellitus
2 other identifiers
interventional
23
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether the adjunctive use of hyaluronic acid (HA) improves periodontal healing in people with diabetes mellitus and periodontitis. The effects of HA on biomolecules and bacteria levels will be assessed during the follow-up period. The main questions the study will answer are:
- Will periodontal sites treated with non-surgical periodontal treatment (NSPT) plus HA gel show better clinical periodontal parameters than sites treated with only NSPT in patients with diabetes and periodontitis?
- will HA gel have additional effect on reducing inflammation or collagen markers, and bacteria levels during follow-up? Researchers will compare periodontal sites receiving NSPT with adjunctive HA gel application to sites receiving NSPT alone to determine whether HA provides additional clinical, biochemical and microbiological benefits. Participants will:
- provide recent HbA1c test results.
- then, the participants will receive full-mouth NSPT then, randomization will be performed for the selected jaw for test sites. These two interproximal test sites will additionally receive HA application.
- attend follow-up visits at 1, 3 and 6 months for clinical periodontal measurements and to provide gingival crevicular fluid samples (GCF) and subgingival samples. The GCF samples will be evaluated for interleukin-34 (IL-34) and beta C-terminal telopeptide (β-CTX) levels and subgingival samples for periodontal pathogens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
June 8, 2026
June 1, 2026
2.1 years
May 12, 2026
June 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Clinical Attachment Level
Clinical attachment level (CAL) will be measured in millimeters using a periodontal probe. The change in CAL will be calculated as the difference between baseline and follow-up measurements. A decrease in CAL indicates an improvement in periodontal attachment.
Baseline, 1, 3 and 6 months after NSPT
Change in Probing Depth
Probing depth will be measured around each tooth by recording the distance in millimeters from the gingival margin to the bottom of the pocket at 6 locations (mesiobuccal, mid-buccal, distobuccal, mesiopalatal, mid-palatal, distopalatal).
Baseline, 1, 3 and 6 months after NSPT
Secondary Outcomes (10)
Change of Bleeding on Probing (%)
Baseline, 1, 3 and 6 months after NSPT
Change in Plaque Index
Baseline, 1, 3 and 6 months after NSPT
Change in Gingival Index
Baseline, 1, 3 and 6 months after NSPT
Change in GCF IL-34 Levels
Baseline, 1, 3 and 6 months after NSPT
Change in GCF β-CTX Levels
Baseline to 1, 3 and 6 months after NSPT
- +5 more secondary outcomes
Study Arms (2)
Test
ACTIVE COMPARATORNon-surgical periodontal treatment and Hyaluronic Acid gel
Control
OTHERNon-surgical periodontal treatment alone
Interventions
Scaling and root planing is a conventional gold-standard treatment for periodontitis. As part of this procedure, subgingival plaque and tartar are removed and root surfaces are planed.
Hyaluronic acid will be locally applied to periodontal pockets as an adjunct to non-surgical periodontal therapy, aiming to support periodontal healing. After completion of scaling and root planing, the material will be delivered subgingivally to designated test sites in a split-mouth design.
Eligibility Criteria
You may qualify if:
- Individuals who sign the informed consent form
- Participants diagnosed with diabetes mellitus (HbA1c %7-7.9)
- Participants without any systemic disease other than DM
- Participants diagnosed with Stage III or Stage IV periodontitis
- Nonsmokers
- Participants with at least 15 natural teeth present in the mouth (excluding third molars)
- Participants in either of the jaws, in both quadrants, having two non-adjacent interproximal sites with probing depth and clinical attachment level ≥6 mm with no caries, restorations or furcation involvement
You may not qualify if:
- Individuals who do not sign the informed consent form
- Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis
- Participants have received any periodontal treatment within 6 months prior to the study
- Participants who have used antibiotics within the last 3 months
- Smokers
- Participants who are pregnant or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Periodontology, Faculty of Dentistry, Marmara University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2026
First Posted
June 8, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
June 8, 2026
Record last verified: 2026-06